Delta-like 4 and vasohibin 1: Two endothelium-produced negative regulators of angiogenesis with distinctive roles

European Cytokine Network

Volumn 20, Issue 4, 2009, Pages 220-224

  Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Autoregulation; Endothelium; Negative feedback

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIC FACTOR DELTA LIKE 4; NOTCH RECEPTOR; UNCLASSIFIED DRUG; VASOHIBIN 1;

AMINO ACID SEQUENCE; ANGIOGENESIS; AUTOREGULATION; CARCINOGENESIS; CELL DISRUPTION; CELL PROLIFERATION; DNA MICROARRAY; ENDOTHELIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; IMMUNOHISTOCHEMISTRY; MAMMAL; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STABILITY; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; ZEBRA FISH;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL CYCLE PROTEINS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 72249087224     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2009.0173     Document Type: Review

References (44)

1. Sato Y. Update on endogenous inhibitors of angiogenesis. Endothelium 2006; 13: 147.
2. Ehebauer M, Hayward P, Arias AM. Notch, a universal arbiter of cell fate decisions. Science 2006; 314: 1414. (Pubitemid 44871939)
3. Shutter JR, Scully S, Fan W, et al. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev 2000; 14: 1313. (Pubitemid 30397075)
4. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 2001; 108: 161. (Pubitemid 32918185)
5. Lawson ND, Scheer N, Pham VN, et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001; 128: 3675. (Pubitemid 32998917)
6. Zhong TP, Childs S, Leu JP, Fishman MC. Gridlock signalling pathway fashions the first embryonic artery. Nature 2001; 414: 216. (Pubitemid 33051237)
7. Krebs LT, Xue Y, Norton CR, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 2000; 14: 1343. (Pubitemid 30397078)
8. Duarte A, Hirashima M, Benedito R, et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 2000; 18: 2474.
9. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 2004; 18: 2469. (Pubitemid 39362888)
10. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 2004; 18: 901. (Pubitemid 38529659)
11. Gale NW, Dominguez MG, Noguera I, et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 2004; 101: 15949. (Pubitemid 39507907)
12. Limbourg FP, Takeshita K, Radtke F, Bronson RT, Chin MT, Liao JK. Essential role of endothelial Notch1 in angiogenesis. Circulation 2005; 111: 1826. (Pubitemid 40525149)
13. Siekmann AF, Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007; 445: 781.
14. Hellstrom M, Phng LK, Hofmann JJ, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007; 445: 776. (Pubitemid 46279716)
15. Leslie JD, Ariza-McNaughton L, Bermange AL, McAdow R, Johnson SL, Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 2007; 134: 839. (Pubitemid 46795675)
16. Liu ZJ, Shirakawa T, Li Y, et al. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 2003; 23: 14. (Pubitemid 36008497)
17. Lobov IB, Renard RA, Papadopoulos N, et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 2007; 104: 3219. (Pubitemid 46364140)
18. Williams CK, Li JL, Murga M, Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 2006; 107: 931. (Pubitemid 43156289)
19. Suchting S, Freitas C, le Noble F, et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 2007; 104: 3225. (Pubitemid 46364141)
20. Williams CK, Segarra M, Sierra Mde L, Sainson RC, Tosato G, Harris AL. Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells. Cancer Res 2008; 68: 1889.
21. Phng LK, Potente M, Leslie JD, et al. Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev Cell 2009; 16: 70.
22. Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 2005; 65: 8690. (Pubitemid 41377356)
23. Patel NS, Dobbie MS, Rochester M, et al. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Clin Cancer Res 2006; 12: 4836. (Pubitemid 44338568)
24. Noguera-Troise I, Daly C, Papadopoulos NJ, et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006; 444: 1032. (Pubitemid 46018516)
25. Ridgway J, Zhang G, Wu Y, et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006; 444: 1083. (Pubitemid 46018529)
26. Li JL, Sainson RC, Shi W, et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 2007; 67: 11244. (Pubitemid 350248550)
27. Segarra M, Williams CK, Sierra Mde L, et al. Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood 2008; 112: 1904.
28. Abe M, Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-induced human umbilical vein endothelial cells. Angiogenesis 2001; 4: 289. (Pubitemid 34832374)
29. Watanabe K, Hasegawa Y, Yamashita H, et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest 2004; 114: 898. (Pubitemid 39578717)
30. Shibuya T, Watanabe K, Yamashita H, et al. Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler Thromb Vasc Biol 2006; 26: 1051. (Pubitemid 43732111)
31. Shimizu K, Watanabe K, Yamashita H, et al. Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells. Biochem Biophys Res Commun 2005; 327: 700. (Pubitemid 40092806)
32. Kern J, Bauer M, Rychli K, et al. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation. Arterioscler Thromb Vasc Biol 2008; 28: 478.
33. Sonoda H, Ohta H, Watanabe K, Yamashita H, Kimura H, Sato Y. Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin. Biochem Biophys Res Commun 2006; 342: 640. (Pubitemid 43289038)
34. Nimmagadda S, Geetha-Loganathan P, Pröls F, Scaal M, Christ B, Huang R. Expression pattern of Vasohibin during chick development. Dev Dyn 2007; 236: 1358. (Pubitemid 46750268)
35. Kimura H, Miyashita H, Suzuki Y, et al. Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood 2009; 113: 4810.
36. Yamashita H, Abe M, Watanabe K, et al. Vasohibin prevents arterial neointimal formation through angiogenesis inhibition. Biochem Biophys Res Commun 2006; 345: 919. (Pubitemid 43776484)
37. Yoshinaga K, Ito K, Moriya T, et al. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. Cancer Sci 2008; 99: 914. (Pubitemid 351997593)
38. Wakusawa R, Abe T, Sato H, et al. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes. Am J Ophthalmol 2008; 146: 235.
39. Tamaki K, Moriya T, Sato Y, et al. Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci 2008; 100: 88.
40. Sato H, Abe T, Wakusawa R, et al. Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetologia 2009; 52: 359.
41. Hosaka T, Kimura H, Heishi T, et al. Vasohibin-1 expressed in endothelium of tumor vessels regulates angiogenesis. Am J Pathol 2009; 175: 430.
42. Shen J, Yang X, Xiao WH, Hackett SF, Sato Y, Campochiaro PA. Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J 2006; 20: 723. (Pubitemid 46671194)
43. Lejmi E, Leconte L, Pédron-Mazoyer S, et al. Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B. Proc Natl Acad Sci USA 2008; 105: 12491.
44. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353. (Pubitemid 26272076)